Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,440,624 papers from all fields of science
Search
Sign In
Create Free Account
Tic disorder
Known as:
Tic
, Tic Disorders [Disease/Finding]
, habit disorder
Expand
Disorders characterized by recurrent TICS that may interfere with speech and other activities. Tics are sudden, rapid, nonrhythmic, stereotyped motor…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
22 relations
Narrower (9)
Behavioral tic
Chronic Motor or Vocal Tic Disorder
Gilles de la Tourette syndrome
Motor Tic Disorders
Expand
Clonazepam
In Blood
Involuntary muscle contraction
Microbiological
Expand
Broader (4)
Extrapyramidal and movement disorders
Movement Disorders
Symptoms
nervous system disorder
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Characterization and Analysis of Tetranitrate Esters
J. Oxley
,
James L. Smith
,
J. Brady
,
Austin C. Brown
2012
Corpus ID: 13841069
Thermal behaviors, vapor pressures, densities, and drop weight impact results, as well as analytical protocols, are reported for…
Expand
Highly Cited
2007
Highly Cited
2007
A candidate precursor to serous carcinoma that originates in the distal fallopian tube (J Pathol 2007; 211: 26–35)
Yonghee Lee
,
Alexander Miron
,
+10 authors
Christopher P. Crum
Journal of Pathology
2007
Corpus ID: 15572963
The tubal fimbria is a common site of origin for early (tubal intraepithelial carcinoma or TIC) serous carcinomas in women with…
Expand
Highly Cited
2006
Highly Cited
2006
Fabrication of porous polymer monoliths in polymeric microfluidic chips as an electrospray emitter for direct coupling to mass spectrometry.
M. Bedair
,
R. Oleschuk
Analytical Chemistry
2006
Corpus ID: 19920763
Coupling of polymeric microfluidic devices to mass spectrometry is reported using porous polymer monoliths (PPM) as…
Expand
Highly Cited
2005
Highly Cited
2005
Supernova graphite in the NanoSIMS: Carbon, oxygen and titanium isotopic compositions of a spherule and its TiC sub-components
F. Stadermann
,
T. Croat
,
+4 authors
E. Zinner
2005
Corpus ID: 33945993
Highly Cited
2004
Highly Cited
2004
Controlled Growth of Y-Junction Nanotubes Using Ti-Doped Vapor Catalyst
N. Gothard
,
C. Daraio
,
J. Gaillard
,
R. Zidan
,
S. Jin
,
A. Rao
2004
Corpus ID: 30232676
We demonstrate a bulk process for the synthesis of Y-junction carbon nanotubes using Ti-doped Fe catalysts. It is shown that the…
Expand
Highly Cited
2004
Highly Cited
2004
Magnetron-sputtered nc-TiC/a-C(Al) tough nanocomposite coatings
Sam Zhang
,
X. Bui
,
Y. Fu
2004
Corpus ID: 53579510
Highly Cited
2003
Highly Cited
2003
Structural, chemical, and isotopic microanalytical investigations of graphite from supernovae
T. Croat
,
T. Bernatowicz
,
S. Amari
,
S. Messenger
,
F. Stadermann
2003
Corpus ID: 6849981
Highly Cited
2002
Highly Cited
2002
Application of pulse discharge sintering (PDS) technique to rapid synthesis of Ti3SiC2 from Ti/Si/C powders
Zhe-feng Zhang
,
Zhengming Sun
,
H. Hashimoto
,
T. Abe
2002
Corpus ID: 53638209
Highly Cited
2002
Highly Cited
2002
In Situ TEM Studies of Metal–Carbon Reactions
R. Sinclair
,
T. Itoh
,
R. Chin
Microscopy and Microanalysis
2002
Corpus ID: 44680463
The reactions which occur between amorphous carbon and a number of first transition metals (Ti, Cr, Fe, Co, Ni, and Cu) have been…
Expand
Highly Cited
1997
Highly Cited
1997
Results of a consecutive series of patients receiving only antiplatelet therapy after optimized stent implantation. Comparison of aspirin alone versus combined ticlopidine and aspirin therapy.
R. Albiero
,
P. Hall
,
+5 authors
A. Colombo
Circulation
1997
Corpus ID: 24545475
BACKGROUND Previous studies have shown that stents can be inserted in coronary arteries of patients who are subsequently treated…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE